Finnrick - Ensuring a Safer and More Transparent Supply Chain
Hangzhou Mandy Biotechnology

Hangzhou Mandy Biotechnology
Retatrutide

Finnrick tested 7 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Hangzhou Mandy Biotechnology between 17 Nov 2025 and 3 Mar 2026. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).

Finnrick Rating™
C
OKAY
Hangzhou Mandy Biotechnology
Retatrutide
Tested 7 Samples
Last test 3 Mar 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Retatrutide tests from Hangzhou Mandy Biotechnology

Samples are tested in commercial labs

Tests Count

7

Scores

AVG7.1MIN4.4MAX9.8

Last

3 Mar 2026

First

17 Nov 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
3 Mar 2026View6.610mg10.1mg+1.0%99.28%(no batch ID)No Label / Silver Crimp / Green CapLab EPublic
22 Jan 2026View4.420mg29.7mg+48.5%99.80%(no batch ID)White Label / Copper Crimp / Clear CapLab GPublic
15 Jan 2026View8.710mg10.1mg+1.0%99.37%MBRT10251116CBLWhite Label / Silver Crimp / Clear Blue CapLab EPublic
17 Dec 2025View9.810mg9.46mg-5.4%99.89%Sept 7,2025White Label / Silver Crimp / White CapLab EPublic
4 Dec 2025View6.820mg21.1mg+5.5%99.50%(no batch ID)No Label / Silver Crimp / Violet CapLab EPublic
25 Nov 2025View8.010mg9.77mg-2.3%99.95%(no batch ID)No Label / Silver Crimp / Clear Blue CapLab EPublic
17 Nov 2025View5.520mg21.4mg+7.0%99.07%(no batch ID)No Label / Copper Crimp / Clear CapLab EPublic